In a recent webinar, Dalia Rosano Imperial College London) discussed breast cancer and epigenetic combination therapies.

Three different treatment strategies are currently under investigation to determine how to optimally improve upon tamoxifen: an aromatase inhibitor as a replacement for 5 years of tamoxifen (early ...

A nurse practitioner discussed considerations for managing aromatase inhibitor-related joint pain in patients with breast ...

Hormonal therapy, particularly the use of aromatase inhibitors (which block the production of estrogen), is a standard treatment after breast cancer surgery for postmenopausal women. While these ...

New evidence shows that extended estrogen suppression treatment using aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of ...

Researchers found that 44.8% of the 357 patients exhibited coronary artery calcium; groups had no significant difference in aromatase inhibitor treatment duration. HealthDay News — For ...

For patients with hormone receptor (HR)-positive, HER2-negative early breast cancer, the combination of Kisqali (ribociclib) and nonsteroidal aromatase inhibitor (NSAI) therapy resulted in sustained ...

N ew evidence shows that extended estrogen suppression treatment using an aromatase inhibitors for hormone receptor-positive ...

I have been on an aromatase inhibitor for the past eight months and have side effects that keep me from having a good quality of life. I am supposed to be on it for five years, but I do not want to ...

Hormonal therapy, particularly the use of aromatase inhibitors (which block the production of estrogen), is a standard treatment after breast cancer surgery for postmenopausal women.

Kisqali has been FDA-approved with an aromatase inhibitor as postsurgical treatment for some with early breast cancer at a high risk of recurrence. The Food and Drug Administration (FDA) has approved ...

Patients, pathologists, clinicians, researchers, radiologists and others from around the world recently gathered for the 2024 ...